Literature DB >> 2457062

An abnormal calcium uptake pump in Chediak-Higashi neutrophil lysosomes.

B Styrt1, C R Pollack, M S Klempner.   

Abstract

Calcium is mobilized from intracellular stores during phagocyte activation and appears to be involved in stimulus-response coupling in these and other cell types. Because the lysosome is a calcium-sequestering organelle in the neutrophil and abnormal lysosome morphology is associated with defective neutrophil function in Chediak-Higashi syndrome (CHS), we examined ATP-dependent calcium uptake in neutrophil lysosomes from the beige mouse model of CHS. We present findings indicating that CHS lysosomes have an enhanced capacity for ATP-dependent calcium uptake relative to control lysosomes. Kinetic analysis showed differences in Vmax and in the Km for both ATP and calcium, suggesting that both the number of lysosomal calcium uptake pumps and their substrate affinity may be altered in CHS. We conclude that a genetically determined abnormality of a subcellular calcium transport system may contribute to the structural and functional defects of CHS cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457062     DOI: 10.1002/jlb.44.2.130

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  Lysosomes shape Ins(1,4,5)P3-evoked Ca2+ signals by selectively sequestering Ca2+ released from the endoplasmic reticulum.

Authors:  Cristina I López-Sanjurjo; Stephen C Tovey; David L Prole; Colin W Taylor
Journal:  J Cell Sci       Date:  2012-10-24       Impact factor: 5.285

2.  Intracellular two-phase Ca2+ release and apoptosis controlled by TRP-ML1 channel activity in coronary arterial myocytes.

Authors:  Ming Xu; Xiaoxue Li; Scott W Walsh; Yang Zhang; Justine M Abais; Krishna M Boini; Pin-Lan Li
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-02       Impact factor: 4.249

3.  On the move, lysosomal CAX drives Ca2+ transport and motility.

Authors:  Emyr Lloyd-Evans
Journal:  J Cell Biol       Date:  2016-03-28       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.